Otonomy Inc

Ticker OTIC

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

51-200 Employees
Based in San Diego, California

Otonomy, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of diseases and disorders of the ear in the United States and Canada. Its lead product candidate is AuriPro, a sustained-exposure antibiotic, which completed Phase III clinical trials to treat pediatric patients with middle ear effusion or fluid at…More

Visit website

Social Media Links

REPORT RATINGS

4.8 / 5.0 (96)

Otonomy Inc reports have an aggregate usefulness score of 4.8 based on 96 reviews.

Otonomy Inc

Most Recent Annual Report

MOST RECENT 2021 Annual Report and Form 10K

View PDF View Form 10K (HTML)

Otonomy Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.